Lisa Wyman

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Scholar Rock Holding Corp publishes a filing, an earnings call transcript or a press release.

Get SRRK alerts

About Lisa Wyman

Lisa Wyman is recorded as Board Member at PepGen Inc. (PEPG) since January 1, 2025 and Board Member at Scholar Rock Holding Corp (SRRK) since January 1, 2025. The newest filing on record that lists Lisa Wyman as Board Member at PepGen Inc. (PEPG) is dated April 28, 2026. The newest filing on record that lists Lisa Wyman as Board Member at Scholar Rock Holding Corp (SRRK) is dated April 22, 2026. PepGen Inc. reported in an 8-K filed March 31, 2025 that Lisa Wyman was appointed Class I director, effective March 27, 2025. Scholar Rock Holding Corp reported in an 8-K filed January 29, 2025 that Lisa Wyman was appointed Chief Technical and Quality Officer. Scholar Rock Holding Corp reported in an 8-K filed January 29, 2025 that Lisa Wyman was appointed Chief Technical and Quality Officer, effective January 27, 2025. PepGen Inc. is classified in the Biotechnology industry within the Healthcare sector. Scholar Rock Holding Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at PepGen Inc. includes Noel Donnelly (CFO), Mary Beth DeLena (General Counsel), Habib J. Dable (Board Member) and 3 others.

“On March 27, 2025, the Board of Directors (the "Board") of PepGen Inc. ("PepGen" or the "Company"), on the recommendation of the Nominating and Corporate Governance Committee of the Board, unanimously appointed Mitchell Finer, Ph.D. and Lisa Wyman to fill newly created vacancies on the Board resulting from the expansion of the number of members of the Board from six to eight.”

PepGen Inc. Form 8-K, filed March 31, 2025 · Read the filing

“Lisa Wyman has been appointed to the new role of Chief Technical and Quality Officer (CTQO) to support the Company's ongoing growth and evolution to becoming a fully integrated biopharma company as it prepares for its first expected drug approval and commercial launch in 2025.”

Scholar Rock Holding Corp Form 8-K, filed January 29, 2025 · Read the filing

Affiliation history

Scholar Rock Holding Corp (SRRK)
Proxy statement

Current
2025-01-27–present

Last confirmed April 22, 2026
PepGen Inc. (PEPG)
Board Member

Proxy statement

Current
2025-01-01–present

Last confirmed April 28, 2026
Scholar Rock Holding Corp (SRRK)
Board Member

Proxy statement

Current
2025-01-01–present

Last confirmed April 22, 2026